Skip to main content
ADMA
NASDAQ Life Sciences

ADMA Biologics 启动 1.25 亿美元加速股回购计划，作为 2026 年约 2 亿美元回购计划的一部分

feedReported by Unknown
Sentiment info
Positive
Importance info
8
Price
$15.97
Mkt Cap
$3.708B
52W Low
$13.5
52W High
$25.67
Market data snapshot near publication time

summarizeSummary

ADMA Biologics 已宣布了一项重大资本回报计划，启动了一项与 JPMorgan 合作的 1.25 亿美元加速股回购 (ASR) 计划。这项 ASR 是更广泛计划的一部分，计划在 2026 年全年回购约 2 亿美元的普通股，通过其 2.25 亿美元循环信贷设施的借款来资助。该公司最初将收到约 640 万股。这一举动是在公司最近报告 2025 年全年财务结果创纪录之后，包括收入和调整后 EBITDA 的强劲增长，表明了公司的良好财务状况。大量的股回购计划表明管理层对公司估值的信心以及增强股东价值的承诺，这对于投资者来说是一个重要事件。

在该公告发布时，ADMA的交易价格为$15.97，交易所为NASDAQ，所属行业为Life Sciences，市值约为$37.1亿。 52周交易区间为$13.50至$25.67。 这则新闻被评估为积极市场情绪，重要性评分为8/10。 来源：Unknown。

show_chartPrice Chart

Share this article

Copied!

feed ADMA - Latest Insights

ADMA
Apr 15, 2026, 4:30 PM EDT
Filing Type: DEF 14A
Importance Score:
7
ADMA Biologics Details Strong 2025 Performance, Executive Compensation, and Pipeline Progress in Definitive Proxy
Sentiment: Positive
View Wiseek Article
ADMA
Mar 28, 2026, 6:18 AM EDT
Source: Access Newswire
Importance Score:
7
Law Firm Investigates ADMA Biologics for Securities Fraud After 29% Stock Plunge
Sentiment: Negative
View Wiseek Article
ADMA
Mar 27, 2026, 7:05 AM EDT
Filing Type: 8-K
Importance Score:
8
ADMA Biologics Issues Detailed Rebuttal to Short-Seller Allegations with Supporting Data
Sentiment: Positive
View Wiseek Article
ADMA
Mar 27, 2026, 7:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
ADMA Biologics Rejects Short-Seller Claims, Citing Strong ASCENIV Demand and Industry-Standard Inventory
Sentiment: Neutral
View Wiseek Article
ADMA
Mar 25, 2026, 6:30 AM EDT
Source: GlobeNewswire
Importance Score:
8
Misleading Short-Seller Report Allegations Rebutted by ADMA Biologics
Sentiment: Negative
View Wiseek Article
ADMA
Mar 02, 2026, 7:13 AM EST
Source: Unknown
Importance Score:
8
ADMA Biologics Launches $125M Accelerated Share Repurchase, Part of ~$200M 2026 Buyback Plan
Sentiment: Positive
View Wiseek Article
ADMA
Mar 02, 2026, 7:05 AM EST
Filing Type: 8-K
Importance Score:
9
ADMA Biologics Launches $125M Accelerated Share Repurchase, Part of $200M 2026 Capital Return Plan
Sentiment: Positive
View Wiseek Article
ADMA
Feb 25, 2026, 5:16 PM EST
Filing Type: 10-K
Importance Score:
8
ADMA Biologics Reports Record 2025 Financials, Driven by ASCENIV Growth and Strategic Initiatives
Sentiment: Positive
View Wiseek Article
ADMA
Feb 25, 2026, 4:11 PM EST
Filing Type: 8-K
Importance Score:
8
ADMA Biologics Reports Record 2025 Financial Results, Strong 2026-2029 Guidance, and Smooth CFO Transition
Sentiment: Positive
View Wiseek Article
ADMA
Jan 12, 2026, 8:20 AM EST
Filing Type: 8-K
Importance Score:
8
ADMA Biologics Raises 2026 Guidance, Projects Strong Long-Term Growth to $1.1B Revenue by 2029
Sentiment: Positive
View Wiseek Article